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Abstract
Background: It is unusual for purpura to emerge as a result of drinking alcohol. Such a peculiarity was observed in
a 55-year-old man with a 30-year history of heavy alcohol use.
Case presentation: The Caucasian patient was studied for 11 years during several detoxification treatments. During the
last 2 years of that period, purpuric rashes were newly observed. The asymptomatic purpura was limited to both lower
limbs, self-limiting with abstinence, and reoccurring swiftly with alcohol relapse. This sequence was observed six times,
suggesting a causative role of alcohol or its metabolites. A skin biopsy revealed histological features of purpura
pigmentosa progressiva (termed Schamberg’s disease). Additionally, alcoholic fatty liver disease markedly elevated serum
immunoglobulins (immunoglobulin A and immunoglobulin E), activated T-lymphocytes, and increased C-reactive protein.
In addition, moderate combined (cellular and humoral) immunodeficiency was found. Unlike the patient’s
immunoglobulin A level, his serum immunoglobulin E level fell in the first days of abstinence, which corresponded to the
time of purpura decline. Systemic vasculitis and clotting disorders were excluded. The benign character of the purpura
was supported by missing circulating immune complexes or complement activation. An alcohol provocation test with
vinegar was followed by the development of fresh “cayenne pepper” spots characteristic of Schamberg’s disease.
Conclusions: This case report demonstrates that Schamberg’s disease can be strongly related to alcohol intake, in our
patient most likely as a late complication of severe alcoholism with alcoholic liver disease. Immunologic disturbances
thereby acquired could have constituted a basis for a hypersensitivity-like reaction after ingestion of alcohol.
Schamberg’s disease induction by vinegar may point to an involvement of acetate, a metabolite of ethanol.
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Background
Cutaneous manifestations of alcohol abuse can rarely in-
clude purpura, which at first sight could be related to ac-
quired clotting defects such as thrombocytopenia and
vascular fragility resulting from liver cirrhosis [1, 2]. Pur-
pura is caused by hemorrhage of small vessels in the skin
or mucous membranes and emerges as red or purple spots
that do not blanch upon application of pressure on the
lesion’s surface [3]. Usually, these skin lesions are a
hallmark of coagulation disorders or vasculitis [3], such as
disseminated intravascular coagulation, idiopathic throm-
bocytopenic purpura, Henoch-Schönlein purpura (HSP),
or hypersensitivity (leukocytoclastic) vasculitis [3–7].
There are a few case reports in the literature of purpura
associated with alcohol use. Among them, three were re-
lated to HSP [8–10], one was associated with Sjögren’s
syndrome [11], another one appeared simultaneously with
an aspirin-induced platelet dysfunction [12], and a further
one was suggested to result from thrombotic thrombocy-
topenic purpura due to alcohol binge drinking [13].
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Moreover, pigmented purpuric dermatoses, such as pur-
pura pigmentosa progressiva (termed Schamberg’s disease
[SD]), have been described as being associated with chronic
drinking [14]. SD can occur in every age group from child-
hood to senium, is usually benign and asymptomatic, and
appears preferentially on the lower limbs. The course is
usually persistent and chronic [15], with the exception of
drug-induced transients, considering inflammatory purpura
under the influence of nonsteroidal anti-inflammatory
drugs, acetaminophen, diuretics, meprobamate, ampicillin,
and amlodipine [16–18]. Histologically, SD is characterized
by patchy parakeratosis, mild spongiosis of the stratum
malpighii, and lymphoid capillaritis. Monocytes, histiocytes,
lymphocytes, and occasionally mast cells infiltrate the peri-
vascular area. Endothelial cells swell and proliferate, thus
forming a rhexis of capillary walls promoting diapedesis of
erythrocytes and subsequent deposition of hemosiderin [16,
19]. SD’s etiology is obscure, but antigen and other cellular
immune mechanisms appear to be involved [19–21].
In addition, an abnormal, spasmlike motility of the
capillaries, probably via dysautonomia [22] and stasis
pigmentation [23], have been described as being asso-
ciated with SD.
In this case report, the close interaction of severe alco-
hol abuse and occurrence of SD is demonstrated. For
the first time, to our knowledge, an association of pur-
pura with serum levels of immunoglobulin E (IgE), as
well as the induction of fresh SD purpura via drinking
vinegar, is shown.
Case presentation
An adult Caucasian alcohol-dependent patient who devel-
oped purpura after drinking alcohol was clinically observed
from May 2005 to April 2016 at our institution (Table 1).
The last 2 years (“purpuric phase”; cf. Table 1) were pro-
spectively studied, and the time before that (“nonpurpuric
Table 1 Routine laboratory results at the patient’s multiple admissions
Abbreviations: MCV Mean corpuscular volume, SGOT Serum glutamic oxaloacetic transaminase, SGPT Serum glutamate-pyruvate transaminase, GGT γ-Glutamyltransferase,
CRP C-reactive protein, CK Creatine kinase, n/a Not applicable
Admissions with purpuric rashes are shaded (“purpuric phase”). Reference values are given in boldface type. Pathological laboratory results revealed slightly elevated uric acid
in most measurements (not shown here)
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phase”) was studied retrospectively. In the “purpuric phase,”
a skin biopsy was performed, and routine diagnostics at
every detoxification treatment were expanded by determin-
ation of serum immunoglobulins, complement factors C3
and C4, and circulating immune complexes. Additionally,
abdominal ultrasound as well as cerebral and internal diag-
nostics for clotting defects, collagenoses, and systemic vas-
culitis were performed. A provocation test with vinegar was
performed, assumed to be a challenge test for acetate, one
main metabolite of ethanol [24]. For ethical, therapeutic,
and toxicological reasons, provocation tests using ethanol
itself or acetaldehyde were not performed.
Principal symptoms
During the last 2 years that we followed him at our clinic, a
German-speaking white man of Polish descent (55 years
old, 166 cm in height, 62 kg in weight, single, unemployed,
and living in his own apartment) with a severe alcohol use
disorder had six inpatient detoxification treatments (Table 1).
Upon each admission, his physical examinations revealed
purpuric rashes appearing symmetrically on his lower ex-
tremities that may have followed gravity (Fig. 1a, b). The pa-
tient reported that the purpura had emerged during periods
of excessive drinking of vodka or beer (usually >300 g/day
of ethanol), began to resolve in the first week of abstinence,
Fig. 1 Purpuric rashes at admission (a, b) and blanched lesions with confluent hyperpigmentation after 14 days of controlled alcohol abstinence
(c, d) in November 2015. Fresh purpura (“cayenne pepper” spots) after 24 h of drinking vinegar (50 ml four times daily) (e1 left tibia, e2 right
tibia) in April 2016 at the end of a 10-day inpatient detoxification treatment
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and erupted again after relapsing alcohol use. The skin
rashes were not associated with itching, pain, or functional
restrictions in his lower limbs. He reported no fever, nausea,
vomiting, migrating arthralgia, or abdominal pain in associ-
ation with these rashes. His oral mucosa and other skin
areas were not affected. In the years before presentation, he
had never noticed such skin lesions, which were confirmed
by reviewing his chart records in our hospital (Table 1). Nei-
ther allergic reactions nor flushes were previously or cur-
rently noticed. He had no personal or family history of
atopy, asthma, or purpura and denied using medications or
drugs. The remaining examination showed cerebellar ataxia,
affective lability, difficulties with concentration, and im-
paired memory, all declining with detoxification. Mild ex-
ecutive dysfunction and slight signs of a sensorimotor
polyneuropathy on his lower extremities, as well as an en-
larged liver, persisted after the detoxifications. At the end of
the benzodiazepine-mediated withdrawal treatments, which
lasted 7–21 days, the patient’s purpura always began to
blanch, leaving confluent patches of hyperpigmentation be-
hind (Fig. 1d), which is characteristic of SD [19–21].
Medical and addiction history
The patient reported drinking alcohol nearly daily since he
was 17 years old. In the past 11 years, he had completed
multiple alcohol detoxification treatments in our ward
(Table 1). Several neuropsychiatric and physical sequelae
of heavy alcohol use had been diagnosed, such as alcoholic
fatty liver disease (AFLD), withdrawal seizures and deliria,
polyneuropathy, cerebral and cerebellar atrophy, and per-
sonality change. The patient reported no further diseases
in his history. He drank preferentially large amounts of
vodka and beer containing 200–500 g/day of ethanol and
usually was brought to the hospital by ambulance or care-
givers, when he was found helplessly drunk in the streets or
at home. Upon admission, his blood alcohol concen-
trations were between 0.25 % and 0.42 %. He had
smoked usually up to 30 cigarettes per day since his
early adolescence.
Diagnostic analyses
Routine blood analysis, including cystatin C, ammonium,
and ferritin, were largely normal, except for moderately
increased transaminases and C-reactive protein (CRP),
over the years (Table 1). On his abdominal ultrasound,
signs of AFLD were found, such as enlarged liver com-
bined with increased echogenicity and coarsened echotex-
ture. Serologic tests for hepatitis, HIV, and lues were
negative. Current electrophysiology revealed mild neur-
opathy in his lower limbs. Regarding the hemorrhagic pur-
pura, an underlying bleeding disease or thrombocytopenia
(Table 1) could be reliably excluded. Also, no evidence of
internal or cerebral involvements of vasculitis was found
via repeated neuroimaging (brain computed tomography
[CT] and magnetic resonance imaging [MRI] including
angiography), electrocardiograms, angiology, and phlebo-
logic diagnostics, and thoracic as well as abdominal CT
scans, during the detoxification treatments in the “pur-
puric phase.” Capillary microscopy of the feet revealed no
signs of vasculitis. This was supported by a skin biopsy of
a small purpuric area that revealed characteristic histo-
logical features of SD; that is, a perivascular lymphocytic
infiltrate associated with reactive endothelial changes and
extravasated red blood cells. The vessel walls were intact,
and fibrin and thrombi are lacking (Fig. 2). The patient’s
drinking vinegar was followed by fresh “cayenne pepper”
spots (Fig. 1e1, e2) characteristic of SD [19–21]. These ap-
peared not immediately but 24 h after the patient ingested
the vinegar.
Fig. 2 Histology of the skin biopsy. a There is a light perivascular lymphocytic infiltration in the upper dermis without involvement of the epidermis.
b The blood vessels show endothelial reaction without destruction. An extravasation of red blood cells can be seen (courtesy of Prof. Dr. Kasper, MD,
Institut für Pathologie am Clemenshospital, Münster, Germany)
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Immunodiagnostics comprised the determination of
serum immunoglobulin levels, autoantibodies, circulat-
ing immune complexes, haptoglobin, hemopexin, cryo-
globulins, and complement components C3 and C4, as
well as serum protein electrophoresis, lymphocyte typing,
immunofixation, and Coombs tests. We found markedly
increased serum levels of IgE and IgA (IgA1 and IgA2)
(Table 2). Unlike IgA, the patient’s IgE levels decreased
with detoxification (Table 2). Lymphocyte typing revealed
lowered B-lymphocytes and CD4 T-cells (at average CD4/
CD8 ratio, natural killer cells, and cytotoxic cells) (cf.
Table 2), pointing to a moderate combined (humoral and
cellular) immune deficiency, which is typical for individuals
with severe alcoholism [25]. In addition, a specific response
of the cellular immune system (elevated ratio of activated
T-lymphocytes) was found (cf. Table 2), which may point
to type IV hypersensitivity. The patient’s results were re-
peatedly unremarkable for serum protein electrophoresis,
troponin, and Coombs tests; haptoglobin, hemopexin, cryo-
globulins, IgM, IgG1, and IgG4levels; and complement (C3
and C4) and immunofixation tests. Moreover, we found no
circulating immune complexes (C1q-IgG and C3d-IgG;
evaluated with C1q- and C3d-binding assays) or autoanti-
bodies (antinuclear antibodies, extractable nuclear antigens,
antineutrophil cytoplasmic antibodies, thyroid antibodies,
and liver-specific or anti-histone antibodies).
Serum vitamin tests showed normal values of folic acid
and methylmalonic acid, holotranscobalamin, thiamine, and
pyridoxine and a slightly lowered level of calciferol, which
was substituted. No evidence of proteinuria, hematuria, or
drug abuse was found over the years the patient was
followed at our clinic. Also, no blood was observed in sev-
eral stool tests. At two admissions, the patient’s N-terminal
prohormone of brain natriuretic peptide was slightly ele-
vated and normalized during detoxification. The last two
detoxification treatments were initially associated with gen-
eralized slowing in electroencephalograms and impairments
of delayed recall and visuospatial skills according to the
Montreal Cognitive Assessment, all of which normalized up
to discharge. The patient’s Mini Mental State Examination
score was unremarkable at that time (29 of 30 possible
points). Actually, the patient’s abdominal CT scan and his
normal serum cholinesterase (Table 1), prothrombin time,
international normalized ratio, bilirubin, IgG, IgM, albumin,
and protein electrophoresis laboratory results did not point
to liver cirrhosis, which could have fostered the elevated
serum immunoglobulins and combined immunodeficiency
[25–27]. Nonetheless, even hardly affected liver function
tests do not exclude an inflammatory progression of AFLD
to advanced liver fibrosis [28, 29], which is gradually associ-
ated with these immune system anomalies, too [25, 27]. A
liver biopsy was not performed.
Table 2 Immunodiagnostics in serum
The patient’s immunoglobulin (IgA) level appeared to increase, while his IgE levels fell, in tandem with abstinence days (AD). Reference levels are given in
brackets, and measurements in variable intervals during the same inpatient treatment are shaded. Not shown in this table is the lymphocyte typing done in
September 2015 with the following results: CD19 B-lymphocytes (132–422/μl) 92/μl, CD4 T-cells (645–1289/μl) 612/μl, and activated T-lymphocytes (43–270/μl)
303/μl with a ratio (3.0–12,5 %) of 23.4 %. The immunological results point to a moderate combined cellular immunodeficiency (low CD19 B-lymphocytes, low
CD4 T-cells at normal CD4/CD8 ratio) and a hypersensitivity-like reaction (elevated IgA and IgE with specific response of the cellular immune system [elevated ratio
of activated T-lymphocytes])
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Course of the addiction treatment
During his multiple detoxification therapies (Table 1),
the patient usually developed pronounced alcohol with-
drawal symptoms that were treated with benzodiaze-
pines, and he received thiamine supplementation every
time. In the patient’s several subsequent inpatient re-
habilitation programs, he had not achieved sustainable
abstinence. The number of these treatments was nega-
tively correlated with the duration of his abstinence pe-
riods, finally lasting less than 1 month after treatment.
Therefore, the patient was taken closer to the hospital’s
ambulatory addiction treatment program. In this setting,
his abstinence periods lasted between 1 and 3 months.
Comorbid affective or psychotic disorders could be ex-
cluded, and various anticraving medications were not ef-
fective. Disulfiram was associated with delirium and
seizures in his history and therefore was not applied.
Discussion
This longitudinal observation demonstrates the recurrence
of purpura dependent on the intake of large amounts of al-
cohol, which happened after about 30 years of chronic,
heavy drinking. Differential diagnoses, such as coagulopa-
thies and vasculitis disorders, were excluded, whereas
typical features of SD were found in a skin biopsy. Immu-
nodiagnostics revealed markedly elevated IgE and IgA
levels and activated T-lymphocytes. Symptoms of systemic
IgA-mediated vasculitis (HSP), such as migrating arth-
ralgia, gastrointestinal symptoms, renal dysfunction,
proteinuria, or hematuria [30, 31], were not present.
Furthermore, brain MRI revealed no cerebral micro-
or macroangiopathy or hemorrhagic lesions [32].
Alcohol, liver, and IgA
Acute alcohol binge drinking was recently shown to
stimulate rapidly the humoral immune defense [33], and
the authors of previous reports stated that chronic alco-
hol use is associated with an increase in total serum IgA
with or without liver disease [27]. The degree of liver
injury is strongly correlated with serum IgA activity
[25, 27, 34], most likely due to weakened IgA clearance in
the liver [26]. The majority of basal serum IgA is synthe-
sized in the bone marrow, being the largest lymphoid tissue
in the body. Another big portion of IgA is secreted from
the mucosa, mainly from the intestinal mucosa [26]. It is
assumed that IgA supports the oral tolerance of harmless
antigens, such as nonreplicating proteins or food proteins,
that have leaked into the circulation from the skin, re-
spiratory system, or gastrointestinal tract [26]. At this
juncture, the disturbed gut wall integrity of chronic
drinkers [35] weakens the barrier against penetrating
pathogens. This may play a central role in the stimulation
of large IgA secretion into the circulation, which might
contribute to inflammatory, destructive processes in
alcoholic liver disease [35] that can further potentiate
serum IgA activity due to progressing liver injury. IgA in
patients with alcoholic liver disease may circulate as part
of immune complexes [35], and IgA was found to deposit
in the skin and kidneys in patients with alcoholic liver dis-
ease without purpura [35]. Notably, internal involvement
could be possible on the basis of a case report in which au-
thors described an association of progressive IgA-mediated
nephropathy and liver cirrhosis [36].
The disturbed gut wall integrity could be responsible for
the CRP elevations consistently found in heavy drinkers
(cf. Table 1) [37]. CRP is recognized to be an inflammatory
acute-phase protein, remarkably of hepatic origin.
Alcohol, liver, and IgE
Allergic reactions to pure alcohol or its metabolites [38]
are rare and mainly attributed to IgE-mediated urticaria
or anaphylaxis [39, 40]. Unlike IgA, serum IgE has not
been clearly associated with the severity of liver dysfunc-
tion [39]. Levels of IgE have been found to be increased
and decreased alongside alcohol consumption and abstin-
ence, respectively [39] (cf. Table 2). An alcohol-induced
increase of IgE in the serum might modify the risk for
IgE-mediated allergic sensitization. However, the clinical
relevance has been estimated to be moderate [39]. An as-
sociation of serum IgE elevations and the development of
purpura and renal injury has been described in children
with HSP [41, 42].
Alcohol, liver, and cellular immune system
An unfavorable interaction between heavy alcohol use
and liver injury (as described for the serum IgA activity)
has been shown for the cellular immune system, too
[25]. Chronic alcohol consumption affected both the
number and functioning of circulating CD4 T-cells, and
the more these were affected, the more the liver was dam-
aged [25]. Moreover, the number of activated CD4 T-cells
was described to be increased in individuals with chronic
alcoholism [25], as in our patient (cf. legend of Table 2).
Mechanism of the presented alcohol-related purpura
The mechanism of SD is largely unknown. Adaptations
in cell-mediated immunity contribute to the genesis of
this usually benign condition, deemed to be a capillaritis
by most but not all authors [19–21]. SD affects capillar-
ies close to the surface of the skin, predominantly in the
lower limbs, allowing red blood cells to migrate into the
skin [19–21]. This localization appears to resemble that
of IgA-mediated vasculitis, which is characterized by depos-
ition of IgA-containing circulating immune complexes
within and around cutaneous capillaries [30, 43], and
especially around postcapillary venules (typically leukocyto-
clastic vasculitis in histology) [44]. Intriguingly, SD was as-
sociated with markedly elevated serum IgA levels in our
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patient, too; nevertheless, circulating immunoglobulin com-
plexes or complement activation [45] was not found, con-
firming the benign character of SD. Our patient’s purpura
declined alongside detoxification, while his IgA levels per-
sisted or increased (Table 2). Thus, at first sight, IgA levels
might be merely “bystanders” of chronic alcohol drinking
[27] rather than being directly involved in the pathogenesis
of SD-related purpura. We are not aware of literature de-
scribing a progression from SD to systemic IgA-mediated
vasculitis or an interaction of both diseases. However, IgA
might have facilitated the fragility of cutaneous capillaries
in our patient’s lower limbs, perhaps following gravity.
Mast cells were described to be involved in SD etiology
[16, 19], but a timely correlation with IgE levels, as seen in
our patient, has not been described before. One might
speculate that the alcohol-mediated increase in IgE activ-
ity serves as a “spark” igniting SD purpura, which is usu-
ally chronic [15] but can be transient if it emerges after
the administration of certain drugs, such as alcohol [14].
In our patient, the causative role of alcohol was under-
lined by the close temporal relationship between the oc-
currence of SD purpura and alcohol relapse.
It is worth noting that fresh purpura emerged after
our patient drank vinegar, assumed to be a challenge test
for the consumption of acetate, a metabolite of ethanol
[24]. A similar observation was made in one previous
case report of purpura due to alcohol consumption, not-
ably with deposits of IgA in the dermal vessels but no
histological signs of vasculitis in a biopsy of the purpuric
macules [8]. Administration of 1 ml of 5 % acetic acid,
however, was not followed by purpura [8], suggesting
that technically negligible amounts of ethanol in vinegar
may be “purpurogenic” or that this small amount of pure
acetic acid was simply insufficient to “kindle” purpura.
Over our patient’s years of heavy drinking, acute effects
of alcohol or its metabolites on capillaries (possibly sus-
tainably affected by IgA) involving IgE [8, 39, 46] or not
involving IgE [22, 23, 47, 48] might have sensitized and
eventually boosted the manifestation of purpura. We
favor an IgE-mediated increase in the permeability of cu-
taneous capillaries [46, 48] facilitating the penetration of
erythrocytes into the skin, thereby forming fresh purpura.
We were reluctant to use the term type 1 hypersensitivity
because the purpura did not develop immediately after the
ingestion of alcohol or vinegar and skin-prick tests for etha-
nol or its metabolites were not performed. The patient had
further changes of the immune system, such as activated T-
lymphocytes, that may point to an additional delayed im-
mune mechanism. Moreover, he had a negative history of
previous allergic reactions. An individual genetic makeup
might have predisposed the patient to SD, which was break-
ing through after further adaptations of the immune system
due to several years of heavy drinking, most likely involving
immunologic reactions of alcoholic liver damage and
leakage of the gut wall barrier. In addition, dysautonomia
[22] as well as ethanol- and/or stress-mediated changes in
local skin immunology [25, 49] might be factors promoting
the patient’s alcohol-related SD.
Conclusions
This case report shows that alcohol-related purpura can be
benign, despite occurring for the first time after many years
of frequent and heavy alcohol use, and is not inescapably
related to acquired or activated vasculitis or clotting disor-
ders. Our patient developed a hypersensitivity-like reaction
to ethanol and/or acetate (as shown by raised serum levels
of IgE and IgA as well as activated T-lymphocytes) mani-
festing as SD with recurrent purpura as a consequence of
chronic and heavy drinking. SD purpura should be consid-
ered in the list of dermatologic alcohol use disorders.
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